These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8237797)

  • 61. Serum from patients with restenosis after percutaneous transluminal coronary angioplasty stimulates proliferation of bovine vascular smooth muscle cells under low extracellular calcium condition.
    Shirotani M; Yui Y; Hattori R; Kawai C
    Jpn Circ J; 1991 Jun; 55(6):634-42. PubMed ID: 1875531
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Percutaneous transluminal coronary angioplasty for chronic dialysis patients.
    Takeshita S; Isshiki T; Tagawa H; Yamaguchi T
    J Invasive Cardiol; 1993; 5(9):345-50. PubMed ID: 10146597
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Results (>6 months) of stenting of >1 major coronary artery in multivessel coronary artery disease.
    Hernández-Antolin RA; Alfonso F; Goicolea J; Pérez-Vizcayno MJ; Bañuelos C; Fernández-Ortiz A; Escaned J; Azcona L; Rodriguez A; Fernández C; Macaya C
    Am J Cardiol; 1999 Jul; 84(2):147-51. PubMed ID: 10426330
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transoesophageal pacing echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty.
    Hoffmann R; Kleinhans E; Lambertz H; Flachskampf FA; Uebis R; Buell U; Hanrath P
    Eur Heart J; 1994 Jun; 15(6):823-31. PubMed ID: 8088272
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Brown CL; Cohen CL; Hirsch LJ; King SB; Alexander RW
    Am J Cardiol; 1992 Aug; 70(3):293-9. PubMed ID: 1632391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Six-month outcome after excimer laser coronary angioplasty for diffuse in-stent restenosis in native coronary arteries.
    Hamburger JN; Foley DP; de Feyter PJ; Wardeh AJ; Serruys PW
    Am J Cardiol; 2000 Aug; 86(4):390-4. PubMed ID: 10946030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis.
    Williams DO; Gruentzig AR; Kent KM; Detre KM; Kelsey SF; To T
    Am J Cardiol; 1984 Jun; 53(12):32C-35C. PubMed ID: 6233884
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus.
    Osanai H; Kanayama H; Miyazaki Y; Fukushima A; Shinoda M; Ito T
    Am J Cardiol; 1998 Mar; 81(6):698-701. PubMed ID: 9527077
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short- and long-term results of angioplasty for multiple coronary stenoses.
    Halon DA; Flugelman MY; Shefer A; Shehadeh H; Merdler A; Turgeman Y; Lewis BS
    Isr J Med Sci; 1988 Mar; 24(3):164-71. PubMed ID: 2967264
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coronary angioplasty in patients who undergo multiple vessel angioplasties, and in patients who have multivessel coronary disease.
    Dorros G; Janke LM
    Herz; 1985 Oct; 10(5):281-91. PubMed ID: 2933313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience.
    Roubin GS; King SB; Douglas JS
    Am J Cardiol; 1987 Jul; 60(3):39B-43B. PubMed ID: 2956840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of endothelial cells in restenosis after coronary angioplasty.
    Meurice T; Vallet B; Bauters C; Dupuis B; Lablanche JM; Bertrand ME
    Fundam Clin Pharmacol; 1996; 10(3):234-42. PubMed ID: 8836697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty.
    Popma JJ; van den Berg EK; Dehmer GJ
    Am J Cardiol; 1988 Dec; 62(17):1298-9. PubMed ID: 2973736
    [No Abstract]   [Full Text] [Related]  

  • 74. Restenosis: a challenge for pharmacology.
    Bult H
    Trends Pharmacol Sci; 2000 Jul; 21(7):274-9. PubMed ID: 10871896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Endovascular radiation and restinosis].
    Blanco Castiñeira J; King SB; Chronos N
    Rev Esp Cardiol; 1997 Jul; 50(7):520-8. PubMed ID: 9304179
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Restenosis: Relationship with Thrombosis.
    Sdringola S; Assali A; Anderson HV; Smalling RW
    Curr Interv Cardiol Rep; 2000 Nov; 2(4):285-292. PubMed ID: 11096678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The nature of arterial restenosis after angioplasty.
    Fajardo L-G LF
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):761-3. PubMed ID: 9531358
    [No Abstract]   [Full Text] [Related]  

  • 78. Pathophysiology of atherosclerosis: development, regression, restenosis.
    Adams MR; Kinlay S; Blake GJ; Orford JL; Ganz P; Selwyn AP
    Curr Atheroscler Rep; 2000 May; 2(3):251-8. PubMed ID: 11122751
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.
    Francis SE; Camp NJ; Burton AJ; Dewberry RM; Gunn J; Stephens-Lloyd A; Cumberland DC; Gershlick A; Crossman DC
    Heart; 2001 Sep; 86(3):336-40. PubMed ID: 11514491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of restenosis at one previously dilated coronary site on the probability of restenosis at another previously dilated coronary site.
    Weintraub WS; Brown CL; Liberman HA; Morris DC; Douglas JS; King SB
    Am J Cardiol; 1993 Nov; 72(15):1107-13. PubMed ID: 8237797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.